283 related articles for article (PubMed ID: 23354809)
21. Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirements.
Ulldemolins M; Martín-Loeches I; Llauradó-Serra M; Fernández J; Vaquer S; Rodríguez A; Pontes C; Calvo G; Torres A; Soy D
J Antimicrob Chemother; 2016 Jun; 71(6):1651-9. PubMed ID: 26869692
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactam.
Kim MK; Capitano B; Mattoes HM; Xuan D; Quintiliani R; Nightingale CH; Nicolau DP
Pharmacotherapy; 2002 May; 22(5):569-77. PubMed ID: 12013355
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia.
Cies JJ; Jain J; Kuti JL
Pediatr Blood Cancer; 2015 Mar; 62(3):477-82. PubMed ID: 25328131
[TBL] [Abstract][Full Text] [Related]
24. Population Pharmacokinetics and Pharmacodynamics of Piperacillin/Tazobactam in Patients with Nosocomial Infections.
Chen R; Qian Q; Sun MR; Qian CY; Zou SL; Wang ML; Wang LY
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):363-72. PubMed ID: 25894901
[TBL] [Abstract][Full Text] [Related]
25. Piperacillin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis.
Kanji S; Roberts JA; Xie J; Alobaid A; Zelenitsky S; Hiremath S; Zhang G; Watpool I; Porteous R; Patel R
Ann Pharmacother; 2018 Oct; 52(10):965-973. PubMed ID: 29730948
[TBL] [Abstract][Full Text] [Related]
26. New antibiotic dosing in infants.
Pineda LC; Watt KM
Clin Perinatol; 2015 Mar; 42(1):167-76, ix-x. PubMed ID: 25678003
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
Varghese JM; Jarrett P; Boots RJ; Kirkpatrick CM; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Apr; 43(4):343-8. PubMed ID: 24612982
[TBL] [Abstract][Full Text] [Related]
28. Piperacillin and tazobactam exhibit linear pharmacokinetics after multiple standard clinical doses.
Auclair B; Ducharme MP
Antimicrob Agents Chemother; 1999 Jun; 43(6):1465-8. PubMed ID: 10348772
[TBL] [Abstract][Full Text] [Related]
29. Population pharmacokinetics of piperacillin/tazobactam in critically ill Korean patients and the effects of extracorporeal membrane oxygenation.
Kim YK; Kim HS; Park S; Kim HI; Lee SH; Lee DH
J Antimicrob Chemother; 2022 Apr; 77(5):1353-1364. PubMed ID: 35224630
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary penetration of piperacillin and tazobactam in critically ill patients.
Felton TW; McCalman K; Malagon I; Isalska B; Whalley S; Goodwin J; Bentley AM; Hope WW
Clin Pharmacol Ther; 2014 Oct; 96(4):438-48. PubMed ID: 24926779
[TBL] [Abstract][Full Text] [Related]
31. Population pharmacokinetics of piperacillin using scavenged samples from preterm infants.
Cohen-Wolkowiez M; Benjamin DK; Ross A; James LP; Sullivan JE; Walsh MC; Zadell A; Newman N; White NR; Kashuba AD; Ouellet D
Ther Drug Monit; 2012 Jun; 34(3):312-9. PubMed ID: 22569355
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy.
Álvarez JC; Cuervo SI; Garzón JR; Gómez JC; Díaz JA; Silva E; Sánchez R; Cortés JA
BMC Pharmacol Toxicol; 2013 Nov; 14():59. PubMed ID: 24286231
[TBL] [Abstract][Full Text] [Related]
33. Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients.
Alobaid AS; Wallis SC; Jarrett P; Starr T; Stuart J; Lassig-Smith M; Mejia JL; Roberts MS; Roger C; Udy AA; Lipman J; Roberts JA
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052849
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic evaluation of piperacillin-tazobactam.
Hayashi Y; Roberts JA; Paterson DL; Lipman J
Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):1017-31. PubMed ID: 20636224
[TBL] [Abstract][Full Text] [Related]
35. A pilot study on pharmacokinetic/pharmacodynamic target attainment in critically ill patients receiving piperacillin/tazobactam.
Martínková J; Malbrain ML; Havel E; Šafránek P; Bezouška J; Kaška M
Anaesthesiol Intensive Ther; 2016; 48(1):23-8. PubMed ID: 26588478
[TBL] [Abstract][Full Text] [Related]
36. Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients.
Patel N; Scheetz MH; Drusano GL; Lodise TP
Antimicrob Agents Chemother; 2010 Jan; 54(1):460-5. PubMed ID: 19858253
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam during high volume haemodiafiltration in patients with septic shock.
Tamme K; Oselin K; Kipper K; Tasa T; Metsvaht T; Karjagin J; Herodes K; Kern H; Starkopf J
Acta Anaesthesiol Scand; 2016 Feb; 60(2):230-40. PubMed ID: 26830215
[TBL] [Abstract][Full Text] [Related]
38. Steady-state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients.
Cheatham SC; Fleming MR; Healy DP; Chung CE; Shea KM; Humphrey ML; Kays MB
Int J Antimicrob Agents; 2013 Jan; 41(1):52-6. PubMed ID: 23228881
[TBL] [Abstract][Full Text] [Related]
39. Towards optimizing cefepime/tazobactam (WCK 4282) exposure to achieve efficacy against piperacillin/tazobactam-resistant ESBL infections: dose recommendations for various renal functions, including intermittent haemodialysis, in healthy individuals.
Muller AE; De Winter BCM; Koch BCP
J Antimicrob Chemother; 2024 May; 79(5):1093-1100. PubMed ID: 38507250
[TBL] [Abstract][Full Text] [Related]
40. Optimising piperacillin/tazobactam dosing in paediatrics.
Tornøe CW; Tworzyanski JJ; Imoisili MA; Alexander JJ; Korth-Bradley JM; Gobburu JV
Int J Antimicrob Agents; 2007 Oct; 30(4):320-4. PubMed ID: 17631983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
